NEW YORK (Reuters Health) – Despite the fact that methicillin-resistant Staphylococcus aureus (MRSA) is usually isolated nowadays from purulent skin and soft tissue infections in children, treatment with…
NEW YORK (Reuters Health) – A new study provides more evidence that influenza vaccine reduces major cardiovascular events in patients hospitalized for acute coronary syndrome (ACS). In the…
NEW YORK (Reuters Health) – Ribavirin added to pegylated interferon more than doubles the sustained viral response rate in children with chronic hepatitis C, a multicenter team reports…
NEW YORK (Reuters Health) – For initial treatment of HIV-1 infection, once daily atazanavir plus ritonavir and once-daily efavirenz provide comparable antiviral efficacy when used with either abacavir/lamivudine…
NEW YORK (Reuters Health) – For treatment of uncomplicated skin abscesses, the efficacy of ultrasound-guided needle aspiration is not on par with incision and drainage – it doesn’t…
NEW YORK (Reuters Health) – Patients with pneumonia and blood oxygen saturation less than 90% are usually hospitalized. Yet, results of new study suggest that the threshold for…
NEW YORK (Reuters Health) – The authors of a systematic review and meta-analysis of relevant studies encourage clinicians to exercise good judgment in using the injectable antibiotic tigecycline…
Rosuvastatin should be considered for HIV-positive people with dyslipidemia — and guidelines should be updated to reflect that, suggests a new study. Although guidelines from the Infectious Diseases…
NEW YORK (Reuters Health) – HCV genotype 4, previously limited to Egypt and parts of Africa, has now spread to southern Europe and other parts of world, an…
NEW YORK (Reuters Health) – HIV patients whose regimen includes efavirenz and who experience CNS side effects such as insomnia and nervousness may benefit from a switch to…